首页> 外文期刊>JAMA: the Journal of the American Medical Association >Association of maternal endothelial dysfunction with preeclampsia.
【24h】

Association of maternal endothelial dysfunction with preeclampsia.

机译:孕妇内皮功能障碍与先兆子痫的关系。

获取原文
获取原文并翻译 | 示例
       

摘要

CONTEXT: Preeclampsia is believed to result from release of placental factors that damage maternal vascular endothelium. However, because most studies have been conducted during pregnancy, it has not been possible to separate maternal from placental mechanisms underlying endothelial dysfunction in preeclampsia. OBJECTIVE: To determine whether endothelial function is impaired in nonpregnant women with previous preeclampsia and whether endothelial dysfunction is mediated by oxidative stress. DESIGN AND SETTING: Case-control study conducted at 3 hospital maternity units in London, England, between July 1997 and June 2000. PARTICIPANTS: A total of 113 women with previous preeclampsia (n = 35 with recurrent episodes; n = 78 with a single episode) and 48 women with previous uncomplicated pregnancies, all of whom were at least 3 months (median, 3 years) postpartum. MAIN OUTCOME MEASURES: Brachial artery flow-mediated (endothelium-dependent) and glyceryl trinitrate-induced (endothelium-independent) dilatation were compared between previously preeclamptic women and controls. To investigate oxidative stress, these measurements were repeated after administration of ascorbic acid, 1 g intravenously, in 15 cases and 15 controls. RESULTS: Mean (SD) flow-mediated dilatation was lower in women with previous preeclampsia compared with controls (recurrent group, 0.9% [4.1%]; single-episode group, 2.7% [3.5%]; and control group, 4.7% [4.3%]; P<.001). In contrast, glyceryl trinitrate-induced dilatation was similar in the 3 groups (recurrent, 19.5% [5.9%]; single-episode, 21.0% [8.0%]; and control, 21.0% [8.3%]; P =.65). Impaired flow-mediated dilatation in previously preeclamptic women was not accounted for by recognized vascular risk factors. Ascorbic acid administration increased flow-mediated dilatation in previously preeclamptic women (baseline, 2.6% [3.3%]; after administration, 5.6% [3.0%]; P =.001) but not in controls (baseline, 6.2% [3.3%]; after administration, 6.7% [5.0%]; P =.72). CONCLUSIONS: Our results indicate that endothelial function is impaired in women with previous preeclampsia and is not explained by established maternal risk factors but is reversed by antioxidant ascorbic acid administration.
机译:背景:先兆子痫被认为是由胎盘因子释放所致,后者破坏了母体血管内皮。但是,由于大多数研究是在怀孕期间进行的,因此尚不可能将先兆子痫中将内皮功能障碍下的母体与胎盘机制区分开。目的:确定患有先兆子痫的非妊娠妇女的内皮功能是否受损,以及氧化应激是否介导内皮功能障碍。设计与地点:病例对照研究,于1997年7月至2000年6月在英国伦敦的3个医院妇产科进行。参与者:共有113名先前患有先兆子痫的妇女(n = 35例反复发作; n = 78例单例)发作)和48例先前无并发症妊娠的妇女,她们均在产后至少3个月(中位数为3年)。主要观察指标:比较先前先兆子痫妇女和对照组的肱动脉血流介导的(内皮依赖性)和三硝酸甘油酯诱导的(内皮依赖性)扩张。为了研究氧化应激,在15例病例和15例对照中,静脉注射1 g抗坏血酸后重复进行这些测量。结果:先兆子痫前期妇女的平均(SD)血流介导扩张率低于对照组(复发组0.9%[4.1%];单发作组2.7%[3.5%];对照组4.7%[ 4.3%]; P <.001)。相比之下,三硝酸甘油酯引起的扩张在三组中相似(复发率为19.5%[5.9%];单集为21.0%[8.0%];对照组为21.0%[8.3%]; P = .65) 。先前的子痫前期妇女的血流介导的扩张受损并未被公认的血管危险因素所解释。服用抗坏血酸会使先兆先兆子痫妇女的血流介导的扩张增加(基线,2.6%[3.3%];服用后,升高5.6%[3.0%]; P = .001),而对照组则没有(基线,6.2%[3.3%]) ;给药后为6.7%[5.0%]; P = .72)。结论:我们的结果表明,先兆子痫前期妇女的血管内皮功能受损,但尚无明确的孕产妇危险因素解释,但抗氧化剂抗坏血酸的使用可逆转内皮功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号